Loading the player...
Information
Managing & Treating Dermatologic Emergencies
Length: 59 Minutes
This program will expire and must be completed by 08/29/28.
** Please note this program was a part of the VOCCME 2025. You will not want to choose this program if you completed this individual program as part of the VOCCME 2025. **
This presentation will provide healthcare professionals with essential insights into the critical situations they may encounter in dermatology. Attendees will learn to recognize various dermatological emergencies, such as severe allergic reactions, acute infections, and conditions like toxic epidermal necrolysis and erythema multiforme. The session will focus on the prompt identification, assessment, and management of these urgent cases, emphasizing evidence-based treatment protocols to ensure optimal patient outcomes. Additionally, the presentation will highlight the importance of interdisciplinary collaboration and timely intervention to prevent complications.
Learning Objectives:
• Learners will classify dermatological emergencies, distinguishing them from less urgent skin conditions.
• Learners will identify and describe common dermatological emergencies such as Stevens-Johnson syndrome, toxic epidermal necrolysis, necrotizing fasciitis, and severe drug reactions.
• Learners will identify common complications associated with dermatological emergencies and their impact on patient prognosis.
Accreditation Statements:
This program is co-sponsored by the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and the Osteopathic Physicians and Surgeons of Oregon (OPSO). Both osteopathic associations are accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.
The program has been designated for a maximum of one (1) AOA Category 1-A Credit(s) by the co-sponsors who have authorized the Missouri Association of Osteopathic Physicians and Surgeons to report CME and specialty credits to the AOA commensurate with the extent of the physician's participation in this activity.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this conference for a maximum of one (1) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure:
The Virtual CME Committee, consisting of representatives from the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and the Osteopathic Physicians and Surgeons of Oregon (OPSO), has no relevant financial relationships with any organization producing, marketing, reselling, distributing health care goods or services consumed by, or used on, patients relative to the content of these presentations.
Grievance Policy:
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to the MAOPS Executive Director, who will then forward said grievance to the Virtual CME Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, they can then submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
Eric Yang, MD
Dr. Eric Yang graduated college with a degree in Biochemistry from the University of California, San Diego. He then earned his medical degree from Chicago Medical School at Rosalind Franklin University in Chicago, Illinois. He then completed his internship at Virginia Mason Medical Center and his residency in Dermatology at Brown University/Rhode Island Hospital in Providence, Rhode Island. Dr. Yang subsequently completed an ACGME-accredited Micrographic Surgery and Dermatologic Oncology fellowship at Roger Williams Medical Center in Providence, Rhode Island. Dr. Yang is board-certified in Dermatology by the American Board of Dermatology.
Dr. Yang is a fellow of the American Academy of Dermatology and has served on the AAD Drug Pricing and Transparency Task Force and the Patient Access and Payer Relations Committee. He has authored over 40 journal articles, including the Journal of the American Academy of Dermatology, JAMA Dermatology, Proceedings of the National Academy of Sciences, Pediatrics, and JAMA Network Open.
Dr. Yang discloses he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing goods or services consumed by or used on patients relative to the content of this presentation.
